EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses

Mehrafarin Ashiri, Emily N. Barker, Wenxuan Wang, Caleb Vegh, Andrew Hedman, Shou Liu, Lin Liu, Richard Hemming, Elaine Anjos, Shawn N. Whitehead, Brian L. Mark, Barbara Triggs-Raine

Molecular Therapy Advances · 2026-12 · 34 (4) · 201882

DOI: 10.1016/j.omta.2026.201882 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Therapy Advances, 2026-12. Verfasst von Mehrafarin Ashiri und 11 weiteren Autor:innen. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: CIHR.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Förderung

  • CIHR

Zitieren

APA

Ashiri, M., Barker, E. N., Wang, W., Vegh, C., Hedman, A., Liu, S., Liu, L., Hemming, R., Anjos, E., Whitehead, S. N., Mark, B. L., & Triggs-Raine, B. (2026). Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses. Molecular Therapy Advances, 34(4), 201882. https://doi.org/10.1016/j.omta.2026.201882

Vancouver

Ashiri M, Barker EN, Wang W, Vegh C, Hedman A, Liu S, et al. Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses. Molecular Therapy Advances. 2026;34(4):201882. doi:10.1016/j.omta.2026.201882

BibTeX
@article{Ashiri2026,
  author = {Ashiri, Mehrafarin and Barker, Emily N. and Wang, Wenxuan and Vegh, Caleb and Hedman, Andrew and Liu, Shou and Liu, Lin and Hemming, Richard and Anjos, Elaine and Whitehead, Shawn N. and Mark, Brian L. and Triggs-Raine, Barbara},
  title = {Evaluation of HexM and its high-level mannose 6-phosphorylated form, PhosHexM, as treatments of models of GM2 gangliosidoses},
  journal = {Molecular Therapy Advances},
  year = {2026},
  volume = {34},
  number = {4},
  pages = {201882},
  doi = {10.1016/j.omta.2026.201882}
}
Kostenlos starten →